Who Exports Capecitabine from India — 216 Suppliers Behind a $88.6M Market
India's capecitabine export market is supplied by 216 active exporters who collectively shipped $88.6M across 2,246 shipments. MANKIND PHARMA LIMITED leads with a 35.3% market share, followed by ALKEM LABORATORIES LIMITED and MSN LABORATORIES PRIVATE LIMITED. The top 5 suppliers together control 76.3% of total export value, reflecting a concentrated market structure.
Top Capecitabine Exporters from India — Ranked by Export Value
MANKIND PHARMA LIMITED is the leading capecitabine exporter from India, holding a 35.3% share of the $88.6M market across 2,246 shipments from 216 exporters. The top 5 suppliers — MANKIND PHARMA LIMITED, ALKEM LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, INTAS PHARMACEUTICALS LIMITED — collectively control 76.3% of total export value, indicating a highly concentrated market. Individual shares are: MANKIND PHARMA LIMITED (35.3%), ALKEM LABORATORIES LIMITED (21.2%), MSN LABORATORIES PRIVATE LIMITED (8.4%), EUGIA PHARMA SPECIALITIES LIMITED (5.8%), INTAS PHARMACEUTICALS LIMITED (5.7%).
Top Capecitabine Exporters from India
Ranked by export value · 216 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | MANKIND PHARMA LIMITED CAPECITABINE TABLETS USP 500MG [5872 PACK X 120'S] (CAPECITABINE TABLETS 500MG [PACK: 876 X120'S]CAPECITABINE TABLETS 500MG [PACK: 888 X120'S] | $31.2M | 1 | 35.3% |
| 2 | ALKEM LABORATORIES LIMITED CAPECITABINE TABLETS USP 500MG [5872 PACK X 120'S] (CAPECITABINE TABLETS 500MG [PACK: 876 X120'S]CAPECITABINE TABLETS 500MG [PACK: 888 X120'S] | $18.8M | 1 | 21.2% |
| 3 | MSN LABORATORIES PRIVATE LIMITED CAPECITABINE TABLETS USP 500MG [5872 PACK X 120'S] (CAPECITABINE TABLETS 500MG [PACK: 876 X120'S]CAPECITABINE TABLETS 500MG [PACK: 888 X120'S] | $7.4M | 8 | 8.4% |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED CAPECITABINE TABLETS USP 500MG [5872 PACK X 120'S] (CAPECITABINE TABLETS 500MG [PACK: 876 X120'S]CAPECITABINE TABLETS 500MG [PACK: 888 X120'S] | $5.1M | 7 | 5.8% |
| 5 | INTAS PHARMACEUTICALS LIMITED CAPECITABINE TABLETS USP 500MG [5872 PACK X 120'S] (CAPECITABINE TABLETS 500MG [PACK: 876 X120'S]CAPECITABINE TABLETS 500MG [PACK: 888 X120'S] | $5.0M | 18 | 5.7% |
| 6 | JODAS EXPOIM PRIVATE LIMITED CAPECITABINE TABLETS USP 500MG (120 TABLCAPECITABINE TABLETS 500MGCAPECITABINE TABLETS 500MG 120 TABLETSIN ONE HDPE BOTTLE | $3.7M | 3 | 4.2% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED TARO- CAPECITABINE 500 MGCAPECITABINE 500MG 1X120T ACC-CANADACAXETA 500 TABLETS (CAPECITABINE TABLETS | $3.3M | 10 | 3.7% |
| 8 | INTAS PHARMACEUTICALS LTD CAPECITABINE TABLETS USP 500MG [5872 PACK X 120'S] (CAPECITABINE TABLETS 500MG [PACK: 876 X120'S]CAPECITABINE TABLETS 500MG [PACK: 888 X120'S] | $1.6M | 10 | 1.8% |
| 9 | RELIANCE LIFE SCIENCES PRIVATE LIMITED NAPROCAP 500 (CAPECITABINE TABLETS USP 5QTY:3500 UNITS CAPECITABINE 500 MGCAPECITABINE 500MG-RELIANCE CAPECITABINE TABLETS USP 500MG | $1.4M | 14 | 1.5% |
| 10 | NAPROD LIFE SCIENCES PRIVATE LIMITED CAXETA 500 TABLETS (CAPECITABINE TABLETSNAPROCAP 500 (CAPECITABINE TABLETS USP 5CAPVEX 500 (CAPECITABINE TABLETS USP 500 | $946.4K | 5 | 1.1% |
| 11 | DR REDDYS LABORATORIES LIMITED CAPECITABINE TABLETS USP 500MG [5872 PACK X 120'S] (CAPECITABINE TABLETS 500MG [PACK: 876 X120'S]CAPECITABINE TABLETS 500MG [PACK: 888 X120'S] | $892.2K | 4 | 1.0% |
| 12 | BETA DRUGS LIMITED CAXETA 500 TABLETS (CAPECITABINE TABLETSCAPVEX 500 (CAPECITABINE TABLETS USP 500CAXETA 500 TABLETS CAPECITABINE TABLETS500 MG ACT | $708.5K | 12 | 0.8% |
| 13 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED CAXETA 500 TABLETS (CAPECITABINE TABLETSCAPVEX 500 (CAPECITABINE TABLETS USP 500CAXETA 500 TABLETS CAPECITABINE TABLETS500 MG ACT | $599.5K | 3 | 0.7% |
| 14 | CIPLA LIMITED PHARMA DRUGS & MEDI CAPEXA CAPECITABINEQTY:3500 UNITS CAPECITABINE 500 MGXELOCEL 500(CAPECITABINE TABLETS USP 500 | $596.3K | 4 | 0.7% |
| 15 | VEXXA LIFESCIENCES PVT. LTD. CAXETA 500 TABLETS (CAPECITABINE TABLETSCAPVEX 500 (CAPECITABINE TABLETS USP 500CAXETA 500 TABLETS CAPECITABINE TABLETS500 MG ACT | $541.6K | 1 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Capecitabine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | Not Listed | Yes, as of November | No | Not verified | WHO-GMP certification granted in November 2025. |
| MSN LABORATORIES PRIVATE LIMITED | Approved | Yes, as of October 2 | Yes | 1500 | Holds FDA approval, WHO-GMP certification (October 2025), and EU GMP compliance. |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | Approved | Yes, as of September | Yes | Not verified | FDA-approved, WHO-GMP certified (September 2023), and EU GMP compliant. |
| DR. REDDY'S LABORATORIES LIMITED | Approved | Yes, as of June 2024 | Yes | Not verified | FDA-approved, WHO-GMP certified (June 2024), and EU GMP compliant. |
| CIPLA LIMITED | Approved | Yes, as of August 20 | Yes | Not verified | FDA-approved, WHO-GMP certified (August 2025), and EU GMP compliant. |
| INTAS PHARMACEUTICALS LIMITED | Approved | Yes, as of April 200 | Yes | Not verified | FDA-approved, WHO-GMP certified (April 2007), EU GMP compliant; received FDA war |
| MANKIND PHARMA LIMITED | Not Listed | No | No | Not verified | Received show-cause notice in December 2020 for selling diabetes drug without ma |
| JODAS EXPOIM PRIVATE LIMITED | Not Listed | Yes, as of May 2025 | No | Not verified | WHO-GMP certification granted in May 2025. |
| BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | Not Listed | Yes, as of July 2025 | No | Not verified | WHO-GMP certification granted in July 2025. |
| NAPROD LIFE SCIENCES PRIVATE LIMITED | Not Listed | Yes, as of March 202 | No | Not verified | WHO-GMP certification granted in March 2025. |
TransData Nexus reviewed the regulatory standing of 10 leading Capecitabine exporters from India. 5 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 5 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Capecitabine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Pharma City of India," is a pivotal hub for bulk drug manufacturing. The city contributes approximately 40% of India's bulk drug production, earning it the title of the "Bulk Drug Capital of India." This prominence is bolstered by the presence of Genome Valley, a premier biotech cluster housing over 200 life sciences companies, including global giants like Novartis, Bayer, and Sanofi. The establishment of Hyderabad Pharma City further cements the city's status as a global pharmaceutical manufacturing and research center.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. Vadodara, in particular, is home to Alembic Pharmaceuticals, one of India's oldest pharmaceutical companies, established in 1907. The region's emphasis on formulations makes it a significant player in the production of finished pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates substantial pharmaceutical exports. The region hosts numerous pharmaceutical companies that leverage its strategic location for global distribution. The proximity to international shipping routes and well-established logistics infrastructure enhances the export capabilities of pharmaceutical firms operating in this cluster.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, primarily due to favorable tax incentives. The region offers excise duty exemptions and income tax benefits, attracting numerous pharmaceutical companies to set up manufacturing units. This has led to significant growth in pharmaceutical production, contributing to both domestic supply and exports.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Leverage Hyderabad for APIs: Utilize Hyderabad's capabilities in bulk drug manufacturing for sourcing high-quality active pharmaceutical ingredients (APIs).
- Tap into Gujarat's Formulation Expertise: Collaborate with companies in the Ahmedabad-Vadodara region for access to advanced pharmaceutical formulations.
- Optimize Export Logistics: Partner with firms in the Mumbai-Thane-Raigad belt to enhance export logistics and global distribution channels.
By strategically engaging with these pharmaceutical clusters, companies can optimize their supply chain for Capecitabine, ensuring quality, cost-effectiveness, and reliability.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Capecitabine exporters from India
MANKIND PHARMA LIMITED — Mankind Pharma seeks M&A to boost domestic branded business
Mankind Pharma, India's fourth-largest pharmaceutical company, is actively pursuing mergers, acquisitions, and in-licensing deals to enhance its domestic branded formulation business. - IMPACT: Potential expansion of product portfolio may strengthen Capecitabine export capabilities.
Impact: Potential expansion of product portfolio may strengthen Capecitabine export capabilities.
MANKIND PHARMA LIMITED — Mankind Pharma launches IPO to raise ₹43.2 billion
Mankind Pharma initiated its initial public offering, aiming to raise ₹43.2 billion to fund growth initiatives and reduce debt. - IMPACT: Increased capital may support expansion of manufacturing and export operations, including Capecitabine.
Impact: Increased capital may support expansion of manufacturing and export operations, including Capecitabine.
INTAS PHARMACEUTICALS LIMITED — FDA cites Intas Pharmaceuticals for data integrity violations
The U.S. FDA inspection revealed intentional falsification of laboratory data and destruction of quality-control records at Intas's Sanand, India facility. - IMPACT: Regulatory scrutiny may affect production and export of Capecitabine.
Impact: Regulatory scrutiny may affect production and export of Capecitabine.
Common Questions — Capecitabine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which capecitabine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, MANKIND PHARMA LIMITED leads with 58 recorded shipments worth $31.2M. ALKEM LABORATORIES LIMITED (24 shipments) and MSN LABORATORIES PRIVATE LIMITED (323 shipments) are also established high-volume exporters.
Q How many capecitabine manufacturers are there in India?
India has 216 active capecitabine exporters with a combined export market of $88.6M across 2,246 shipments to 123 countries. The top 5 suppliers hold 76.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for capecitabine from India?
Average FOB unit price: $11.01 per unit, ranging from $0.01 to $373.95. Average shipment value: $39.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 216 verified Indian exporters of Capecitabine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,246 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 123 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,246 Verified Shipments
216 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists